Charles E. Argoff, MD, FABPM
Amy Clouse, MD, FAAFP
Oscar A. de Leon-Casasola, MD
Lisa M. Ferreira, MD, FOMA
Katherine E. Galluzzi, DO, CMD, FACOFP
Jennifer B. Green, MD
Gregory L. Hall, MD
Lawrence Herman, DMSc, MPA, PA-C, DFAAPA
Pallavi Joshi, DO, MA
Jonette Keri, MD, PhD
Pamela Kushner, MD, FAAFP
Paola Lichtenberger, MD
Mylynda B. Massart, MD, PhD
Charles Vega, MD, FAAFP
Karol E. Watson, MD, PhD
Candace Westgate, DO, MPH, FACOG
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Charles E. Argoff, MD, FABPM
- AbbVie, Amgen, Averitas Pharma, Biohaven, Grunenthal, Impel Pharmaceuticals, Kowa Pharmaceuticals America, Lilly, Lundbeck, Nevro, and Teva., Speaker; AbbVie, Amgen, Averitas Pharma, Clexio Biosciences, EnZen Therapeutics, Kowa, Lundbeck, Nevro, Tremeau Pharmaceuticals, Tris Pharma, Vertex and Xgene Pharma., Advisor; AbbVie, Amgen, Lilly, Lundbeck, and Teva., Researcher; Neumentum, PainScript, and Tris Pharma, Consultant; Pfizer and Trevena., Stock Holder (publicly traded company)
- Amy Clouse, MD, FAAFP
- Astellas Pharma, Advisor; Astellas Pharma, Speaker
- Oscar A. de Leon-Casasola, MD
- Kowa Pharmaceuticals, Advisor; Kowa Pharmaceuticals, Consultant
- Lisa M. Ferreira, MD, FOMA
- Elil Lill and Novo Nordisk, Inc., Speaker; Novo Nordisk, Speaker
- Katherine E. Galluzzi, DO, CMD, FACOFP
- No relevant financial relationships disclosed.
- Jennifer B. Green, MD
- Boehringer Ingelheim, Researcher; Lilly, Novo Nordisk, AstraZeneca, and Boehringer Ingelheim, Consultant
- Gregory L. Hall, MD
- No relevant financial relationships disclosed.
- Lawrence Herman, DMSc, MPA, PA-C, DFAAPA
- Novo Nordisk, Speaker
- Pallavi Joshi, DO, MA
- No relevant financial relationships disclosed.
- Jonette Keri, MD, PhD
- Almirall, Advisor; L'Oreal, Advisor; Ortho Dermatologics, Advisor; Primus Pharmaceuticals, Advisor
- Pamela Kushner, MD, FAAFP
- Abbott, Stock Holder (publicly traded company); Janssen, Lilly/BI, AstraZeneca, Bayer, GlaxoSmithKline, Phathom, Astellas, Haleon, and Novo Nordisk., Speaker; Lilly, Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Corcept, Haleon, and Bayer., Consultant; Novo Nordisk, Lilly, Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Abbott, Phathom, Bausch/SALIX, Intuity, Pfizer, and Janssen., Advisor
- Paola Lichtenberger, MD
- No relevant financial relationships disclosed.
- Mylynda B. Massart, MD, PhD
- GRAIL, LLC, Speaker
- Charles Vega, MD, FAAFP
- GlaxoSmithKline and Boehringer Ingelheim, Consultant
- Karol E. Watson, MD, PhD
- Amarin, Consultant; Amgen, Consultant; Boehringer Ingelheim, Consultant; Lilly, Consultant; Novartis, Consultant
- Candace Westgate, DO, MPH, FACOG
- GRAIL, LLC and Myriod Genetics, Consultant; GRAIL, LLC and Myriod Genetics, Speaker
Other Disclosures
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.